These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 15231872

  • 1. Structural and functional analysis of the differential effects of c-Jun and v-Jun on prolactin gene expression.
    Farrow KN, Bradford AP, Tentler JJ, Gutierrez-Hartmann A.
    Mol Endocrinol; 2004 Oct; 18(10):2479-90. PubMed ID: 15231872
    [Abstract] [Full Text] [Related]

  • 2. The Ras and protein kinase C signaling pathways are functionally antagonistic in GH4 neuroendocrine cells.
    Oberwetter JM, Conrad KE, Gutierrez-Hartmann A.
    Mol Endocrinol; 1993 Jul; 7(7):915-23. PubMed ID: 8413316
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression.
    Conrad KE, Oberwetter JM, Vaillancourt R, Johnson GL, Gutierrez-Hartmann A.
    Mol Cell Biol; 1994 Mar; 14(3):1553-65. PubMed ID: 8114693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transcriptional activation by the v-Jun oncoprotein is independent of positive regulatory phosphorylation.
    Black EJ, Catling AD, Woodgett JR, Kilbey A, Gillespie DA.
    Oncogene; 1994 Aug; 9(8):2363-8. PubMed ID: 8036019
    [Abstract] [Full Text] [Related]

  • 7. Jun, the oncoprotein.
    Vogt PK.
    Oncogene; 2001 Apr 30; 20(19):2365-77. PubMed ID: 11402333
    [Abstract] [Full Text] [Related]

  • 8. Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun.
    Oehler T, Pintzas A, Stumm S, Darling A, Gillespie D, Angel P.
    Oncogene; 1993 May 30; 8(5):1141-7. PubMed ID: 8479739
    [Abstract] [Full Text] [Related]

  • 9. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
    Morgan IM, Asano M, Håvarstein LS, Ishikawa H, Hiiragi T, Ito Y, Vogt PK.
    Oncogene; 1993 May 30; 8(5):1135-40. PubMed ID: 8479738
    [Abstract] [Full Text] [Related]

  • 10. Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type.
    Keech CA, Jackson SM, Siddiqui SK, Ocran KW, Gutierrez-Hartmann A.
    Mol Endocrinol; 1992 Dec 30; 6(12):2059-70. PubMed ID: 1337142
    [Abstract] [Full Text] [Related]

  • 11. The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity.
    Conrad KE, Gutierrez-Hartmann A.
    Oncogene; 1992 Jul 30; 7(7):1279-86. PubMed ID: 1620544
    [Abstract] [Full Text] [Related]

  • 12. Differential and antagonistic effects of v-Jun and c-Jun.
    Gao M, Morgan I, Vogt PK.
    Cancer Res; 1996 Sep 15; 56(18):4229-35. PubMed ID: 8797597
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E, Perez S, Castellazzi M.
    Oncogene; 2000 Oct 12; 19(43):5020-9. PubMed ID: 11042689
    [Abstract] [Full Text] [Related]

  • 14. v-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity.
    Fujii M, Minamino T, Nomura M, Miyamoto K, Tanaka J, Seiki M.
    Leukemia; 1997 Apr 12; 11 Suppl 3():402-4. PubMed ID: 9209405
    [Abstract] [Full Text] [Related]

  • 15. Analysis of rat prolactin promoter sequences that mediate pituitary-specific and 3',5'-cyclic adenosine monophosphate-regulated gene expression in vivo.
    Keech CA, Gutierrez-Hartmann A.
    Mol Endocrinol; 1989 May 12; 3(5):832-9. PubMed ID: 2547156
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
    Briggs J, Chamboredon S, Castellazzi M, Kerry JA, Bos TJ.
    Oncogene; 2002 Oct 10; 21(46):7077-91. PubMed ID: 12370830
    [Abstract] [Full Text] [Related]

  • 17. Reconstitution of protein kinase A regulation of the rat prolactin promoter in HeLa nonpituitary cells: identification of both GHF-1/Pit-1-dependent and -independent mechanisms.
    Rajnarayan S, Chiono M, Alexander LM, Gutierrez-Hartmann A.
    Mol Endocrinol; 1995 Apr 10; 9(4):502-12. PubMed ID: 7659093
    [Abstract] [Full Text] [Related]

  • 18. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
    Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA, Muller M.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):127-39. PubMed ID: 15607537
    [Abstract] [Full Text] [Related]

  • 19. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J, Briggs J, Findlay C, Bos T.
    Oncogene; 2000 Oct 05; 19(42):4876-85. PubMed ID: 11039905
    [Abstract] [Full Text] [Related]

  • 20. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
    Angel P, Smeal T, Meek J, Karin M.
    New Biol; 1989 Oct 05; 1(1):35-43. PubMed ID: 2518690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.